SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Koichi Watashi, Ann Sluder, Takuji Daito, Satoko Matsunaga, Akihide Ryo, Shushi Nagamori, Masashi Iwamoto, Syo Nakajima, Senko Tsukuda, Katyna Borroto-Esoda, Masaya Sugiyama, Yasuhito Tanaka, Yoshikatsu Kanai, Hiroyuki Kusuhara, Masashi Mizokami, Takaji Wakita, Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP), Hepatology, 2014, 59, 5
  2. 2
    S. T. Martin, S. M. Cardwell, M. D. Nailor, S. Gabardi, Hepatitis B Reactivation and Rituximab: A New Boxed Warning and Considerations for Solid Organ Transplantation, American Journal of Transplantation, 2014, 14, 4
  3. 3
    Katrina H. McGonigal, Iman E. Bajjoka, Marwan S. Abouljoud, Tenofovir-Emtricitabine Therapy for the Prevention of Hepatitis B Recurrence in Four Patients After Liver Transplantation, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 9
  4. 4
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  5. 5
    Payam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian, Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update, Hepatitis Monthly, 2012, 12, 3, 168

    CrossRef

  6. 6
    Seyed Moayed Alavian, Kamran B. Lankarani, Mario Rizzetto, Alfredo Marzano, Mohsen Moghadami, Saman Nik-Eghbolian, Amin Bahrani, Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran, Hepatitis Monthly, 2012, 12, 12

    CrossRef

  7. 7
    Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten, The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation, Langenbeck's Archives of Surgery, 2012, 397, 5, 697

    CrossRef

  8. 8
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  9. 9
    Marion G. Peters, Monika Sarkar, Sande's HIV/AIDS Medicine, 2012,

    CrossRef

  10. 10
    Seyed-Moayed Alavian, Dilemma of recurrence of hepatitis B infection after liver transplantation, Liver International, 2011, 31, 10
  11. 11
    Stephen E Congly, Kelly W Burak, Carla S Coffin, Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation, Expert Review of Clinical Immunology, 2011, 7, 4, 429

    CrossRef

  12. 12
    C. S. Coffin, P. M. Mulrooney-Cousins, M. G. Peters, G. van Marle, J. P. Roberts, T. I. Michalak, N. A. Terrault, Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy, Journal of Viral Hepatitis, 2011, 18, 6
  13. 13
    Joseph Ahn, Stanley Martin Cohen, Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin, Hepatitis Monthly, 2011, 11, 8, 638

    CrossRef

  14. 14
    Irene N Rapti, Stephanos J Hadziyannis, Treatment of special populations with chronic hepatitis B infection, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 323

    CrossRef

  15. 15
    Florian Bihl, Stefan Russmann, Vanina Gurtner, Loriana Di Giammarino, Loredana Pizzi-Bosman, Martine Michel, Andreas Cerny, Antoine Hadengue, Pietro Majno, Emiliano Giostra, Damiano Castelli, Gilles Mentha, Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation, BMC Gastroenterology, 2010, 10, 1, 71

    CrossRef

  16. 16
    B. Degertekin, Steven-Huy B. Han, E. B. Keeffe, E. R. Schiff, V. A. Luketic, R. S. Brown, Jr., S. Emre, C. Soldevila-Pico, K. R. Reddy, M. B. Ishitani, T. T. Tran, T. L. Pruett, A. S. F. Lok, Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation, American Journal of Transplantation, 2010, 10, 8
  17. 17
    Hui-Hui Tan, Paul Martin, Management of End-Stage Liver Disease in Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 477

    CrossRef

  18. 18
    Shi-Bin Xie, Jian-Yun Zhu, Zhang Ying, Li-Jiao Zeng, Ma Chao, Min-Qiang Lu, Prevention and Risk Factors of the HBV Recurrence After Orthotopic Liver Transplantation: 160 Cases Follow-Up Study, Transplantation, 2010, 90, 7, 786

    CrossRef

  19. 19
    Daniel Shouval, The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients, Digestive and Liver Disease, 2010, 42, 8, 537

    CrossRef

  20. 20
    C. S. Coffin, P. G. Stock, L. M. Dove, C. L. Berg, N. N. Nissen, M. P. Curry, M. Ragni, F. G. Regenstein, K. E. Sherman, M. E. Roland, N. A. Terrault, Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients, American Journal of Transplantation, 2010, 10, 5
  21. 21
    J. STEPHEN DUMMER, NINA SINGH, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  22. 22
    J. STEPHEN DUMMER, LORA D. THOMAS, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  23. 23
    Sammy Saab, Maggie Y. Ham, Michael A. Stone, Curtis Holt, Myron Tong, Decision analysis model for hepatitis B prophylaxis one year after liver transplantation, Liver Transplantation, 2009, 15, 4
  24. 24
    Marion G. Peters, Special populations with hepatitis B virus infection, Hepatology, 2009, 49, S5
  25. 25
    Hiroyuki Tahara, Yuka Tanaka, Kohei Ishiyama, Kentaro Ide, Masayuki Shishida, Toshimitsu Irei, Yuichiro Ushitora, Masahiro Ohira, Masataka Banshodani, Hirotaka Tashiro, Toshiyuki Itamoto, Toshimasa Asahara, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama, Hideki Ohdan, Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness, Transplant International, 2009, 22, 8
  26. 26
    Pierre Loulergue, Odile Launay, Vaccinations chez les patients ayant une cirrhose, La Presse Médicale, 2009, 38, 7-8, 1134

    CrossRef

  27. 27
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  28. 28
    Pierre Loulergue, Stanislas Pol, Vincent Mallet, Philippe Sogni, Odile Launay, Why actively promote vaccination in patients with cirrhosis?, Journal of Clinical Virology, 2009, 46, 3, 206

    CrossRef

  29. 29
    Tao Pan, Ming Cai, Li Tang, Li Qiao Zhou, Bin Jian Li, Tong Zhu, Hong Zhou Li, Shu Yuan Li, Xiao Xiao, Zhi Shui Chen, A novel approach of prophylaxis to HBV recurrence after liver transplantation, Virology, 2008, 382, 1, 1

    CrossRef

  30. 30
    Dianne LaPointe Rudow, Michael J. Goldstein, Critical Care Management of the Liver Transplant Recipient, Critical Care Nursing Quarterly, 2008, 31, 3, 232

    CrossRef

  31. 31
    Anna S. F. Lok, How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting, Liver Transplantation, 2008, 14, S2
  32. 32
    Gideon M. Hirschfield, Teru Kumagi, E. Jenny Heathcote, Preventative hepatology: minimising symptoms and optimising care, Liver International, 2008, 28, 7
  33. 33
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,
  34. 34
    Seyed Mohammad Jazayeri, Seyed Moayed Alavian, Payam Dindoost, Howard C. Thomas, Peter Karayiannis, Molecular Variants of Hepatitis B Surface Antigen (HBsAg),